Patents by Inventor Rajeshwar Singh

Rajeshwar Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10858351
    Abstract: Compounds of formula I that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase, pharmaceutical compositions including such compounds and methods of treating diseases, conditions or disorders utilizing such compounds and compositions.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: December 8, 2020
    Inventors: Praveen Baradi, Damayanthi Yalamati, Rajeshwar Singh
  • Patent number: 10533021
    Abstract: This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: January 14, 2020
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Stephen J. Baker, Vincent S. Hernandez, Rashmi Sharma, James A. Nieman, Tsutomu Akama, Yong-Kang Zhang, Jacob J. Plattner, Michael Richard Kevin Alley, Rajeshwar Singh, Fernando Rock
  • Publication number: 20180312497
    Abstract: Compounds of formula I that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase, pharmaceutical compositions including such compounds and methods of treating diseases, conditions or disorders utilizing such compounds and compositions.
    Type: Application
    Filed: February 9, 2018
    Publication date: November 1, 2018
    Inventors: Praveen Baradi, Damayanthi Yalamati, Rajeshwar Singh
  • Publication number: 20180016285
    Abstract: This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
    Type: Application
    Filed: September 28, 2017
    Publication date: January 18, 2018
    Inventors: Stephen J. Baker, Vincent S. Hernandez, Rashmi Sharma, James A. Nieman, Tsutomu Akama, Yong-Kang Zhang, Jacob J. Plattner, Michael Richard Kevin Alley, Rajeshwar Singh, Fernando Rock
  • Patent number: 9796735
    Abstract: The compounds are of the class of 3,7 substituted benzoxaboroles, useful for killing and/or inhibiting the growth of microorganisms.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: October 24, 2017
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Stephen J. Baker, Vincent S. Hernandez, Rashmi Sharma, James A. Nieman, Tsutomu Akama, Yong-Kang Zhang, Jacob J. Plattner, Michael Richard Kevin Alley, Rajeshwar Singh, Fernando Rock
  • Patent number: 9689856
    Abstract: Compositions and methods are provided for assessing the presence or absence, and optionally quantitating, the surface loading of a noble metal such as platinum on the surface of a substrate. The invention utilizes the decomposition rate of hydrogen peroxide (H2O2) or other redox active molecule following exposure to the substrate surface to effectively establish a qualitative or quantitative correlation between the redox agent survival fraction and the presence or absence of noble metal (e.g., platinum), and further, for the quantitation of noble metal loading on the substrate surface. The invention finds applicability in assessing the surface loading of noble metals on the internal surfaces of boiling water nuclear reactor plants (BWR) that have undergone prior noble metal application.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: June 27, 2017
    Assignee: ELECTRIC POWER RESEARCH INSTITUTE
    Inventors: Susan Elaine Garcia, Thomas Pompilio Diaz, Samson Hettiarachchi, Rajeshwar Singh Pathania
  • Publication number: 20160299115
    Abstract: The present invention provides compositions and methods for assessing the presence or absence, and optionally quantitating, the surface loading of a noble metal such as platinum on the surface of a substrate. The invention utilizes the decomposition rate of hydrogen peroxide (H2O2) or other redox active molecule following exposure to the substrate surface to effectively establish a qualitative or quantitative correlation between the redox agent survival fraction and the presence or absence of noble metal (e.g., platinum), and further, for the quantitation of noble metal loading on the substrate surface. The invention provides advantages over the state of the art, and finds applicability in diverse industries. In some embodiments, the compositions and/or methods of the invention are used to assess the surface loading of noble metals on the internal surfaces of boiling water nuclear reactor plants (BWR) that have undergone prior noble metal application.
    Type: Application
    Filed: April 8, 2016
    Publication date: October 13, 2016
    Applicant: Electric Power Research Institute
    Inventors: Susan Elaine Garcia, Thomas Pompilio Diaz, Samson Hettiarachchi, Rajeshwar Singh Pathania
  • Patent number: 9124564
    Abstract: Techniques are presented for establishing context awareness during first negotiation of secure key exchange. These techniques may be embodied as a method, apparatus or instructions in a computer-readable storage media. At a first network device, a message is received from a second network device as part of an initial exchange of information of a secure key exchange, the message containing information indicating one or more secure key exchange policies acceptable to the second network device and defining one or more associated security parameters. The message further contains context-specific information identifying a context of the second network device. The first network device selects a secure key exchange policy for communicating with the second network device based upon the context-specific information and sends a response message to the second network device containing the selected secure key exchange policy. If the context was understood, the response message also includes context-specific information.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: September 1, 2015
    Assignee: Cisco Technology, Inc.
    Inventors: Thamilarasu Kandasamy, Ly Loi, Rajeshwar Singh Jenwar
  • Publication number: 20150133402
    Abstract: This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
    Type: Application
    Filed: November 7, 2014
    Publication date: May 14, 2015
    Inventors: STEPHEN J. BAKER, VINCENT S. HERNANDEZ, RASHMI SHARMA, JAMES A. NIEMAN, TSUTOMU AKAMA, YONG-KANG ZHANG, JACOB J. PLATTNER, MICHAEL RICHARD KEVIN ALLEY, RAJESHWAR SINGH, FERNANDO ROCK
  • Publication number: 20150058913
    Abstract: Techniques are presented for establishing context awareness during first negotiation of secure key exchange. These techniques may be embodied as a method, apparatus or instructions in a computer-readable storage media. At a first network device, a message is received from a second network device as part of an initial exchange of information of a secure key exchange, the message containing information indicating one or more secure key exchange policies acceptable to the second network device and defining one or more associated security parameters. The message further contains context-specific information identifying a context of the second network device. The first network device selects a secure key exchange policy for communicating with the second network device based upon the context-specific information and sends a response message to the second network device containing the selected secure key exchange policy. If the context was understood, the response message also includes context-specific information.
    Type: Application
    Filed: August 22, 2013
    Publication date: February 26, 2015
    Applicant: Cisco Technology, Inc.
    Inventors: Thamilarasu Kandasamy, Ly Loi, Rajeshwar Singh Jenwar
  • Patent number: 8895534
    Abstract: Novel monosubstituted and disubstutituted oxaboroles and pharmaceutical compositions containing such oxaboroles are provided, which are useful for treating bacterial infections, as well as combinations of these oxaboroles with at least one additional therapeutically effective agent.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: November 25, 2014
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Stephen J. Baker, Vincent S. Hernandez, Rashmi Sharma, James A. Nieman, Tsutomu Akama, Yong-Kang Zhang, Jacob J. Plattner, Michael Richard Kevin Alley, Rajeshwar Singh, Fernando Rock
  • Publication number: 20140011768
    Abstract: Compounds and methods of treating anti-inflammatory conditions are disclosed.
    Type: Application
    Filed: June 11, 2013
    Publication date: January 9, 2014
    Inventors: Tsutomu Akama, Yong-Kang Zhang, Charles Z. Ding, Jacob J. Plattner, Kirk R. Maples, Yvonne Freund, Virginia Sanders, Yi Xia, Stephen J. Baker, James A. Nieman, Xiaosong Lu, Marcelo Sales, Rashmi Sharma, Rajeshwar Singh, Robert Jacobs, Daitao Chen, Michael Richard Kevin Alley
  • Patent number: 8461135
    Abstract: Compounds and methods of treating anti-inflammatory conditions are disclosed.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: June 11, 2013
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Tsutomu Akama, Yong-Kang Zhang, Charles Z. Ding, Jacob J. Plattner, Kirk R. Maples, Yvonne Freund, Virginia Sanders, Yi Xia, Stephen J. Baker, James A. Nieman, Xiaosong Lu, Marcelo Sales, Rashmi Sharma, Rajeshwar Singh, Robert T. Jacobs, Daitao Chen, Michael Richard Kevin Alley
  • Patent number: 8343944
    Abstract: This invention largely relates to 3,4,6-trisubstituted benzoxaborole compounds, and their use for treating bacterial infections.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: January 1, 2013
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Yi Xia, Michael Richard Kevin Alley, Yasheen Zhou, Rajeshwar Singh, Charles Ding, Kathy Cao, Jacob J. Plattner, Ligong Ou, Guofeng Jia, Neerja Saraswat, Sreekanth Ramachandran, Ding Zhou
  • Publication number: 20120214765
    Abstract: Compounds and methods of treating anti-inflammatory conditions are disclosed.
    Type: Application
    Filed: September 19, 2011
    Publication date: August 23, 2012
    Applicant: Anacor Pharmaceuticals, Inc.
    Inventors: Tsutomu Akama, Yong-Kang Zhang, Charles Z. Ding, Jacob J. Plattner, Kirk R. Maples, Yvonne Freund, Virginia Sanders, Yi Xia, Stephen J. Baker, James A. Nieman, Xiaosong Lu, Marcelo Sales, Rashmi Sharma, Rajeshwar Singh, Robert T. Jacobs, Daitao Chen, Michael Richard Kevin Alley
  • Patent number: 8106031
    Abstract: Compositions and methods of use of boron derivatives, including benzoxaboroles, benzazaboroles and benzthiaboroles, as therapeutic agents for treatment of diseases caused by fungi, yeast, bacteria or viruses are disclosed, as well as methods for synthesis of said agents and compositions thereof.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: January 31, 2012
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Ving Lee, Jacob J. Plattner, Stephen J. Benkovic, Stephen J. Baker, Kirk R. Maples, Carolyn Bellinger-Kawahara, Tsutomu Akama, Yong-Kang Zhang, Rajeshwar Singh, Vittorio A. Sauro
  • Patent number: 8039450
    Abstract: Compounds and methods of treating anti-inflammatory conditions are disclosed.
    Type: Grant
    Filed: March 5, 2009
    Date of Patent: October 18, 2011
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Tsutomu Akama, Yong-Kang Zhang, Charles Z. Ding, Jacob J. Plattner, Kirk R. Maples, Yvonne Freund, Virginia Sanders, Yi Xia, Stephen J. Baker, James A. Nieman, Xiaosong Lu, Marcelo Sales, Rashmi Sharma, Rajeshwar Singh, Robert Jacobs, Daitao Chen, Michael Richard Kevin Alley
  • Patent number: 7968752
    Abstract: Compositions and methods of use of borole derivatives, including benzoxaboroles, benzazaboroles and benzthiaboroles, as therapeutic agents for treatment of diseases caused by bacteria or viruses are disclosed, as well as methods for synthesis of said agents and compositions thereof.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: June 28, 2011
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Ving Lee, Jacob J. Plattner, Stephen J. Benkovic, Stephen J. Baker, Kirk R. Maples, Carolyn Bellinger-Kawahara, Tsutomu Akama, Yong-Kang Zhang, Rajeshwar Singh, Vittorio A. Sauro
  • Publication number: 20110136763
    Abstract: This invention largely relates to 3,4,6-trisubstituted benzoxaborole compounds, and their use for treating bacterial infections.
    Type: Application
    Filed: July 27, 2010
    Publication date: June 9, 2011
    Applicants: Anacor Pharmaceuticals, Inc., GlaxoSmithKline LLC
    Inventors: Yi Xia, Michael Richard Kevin Alley, Yasheen Zhou, Rajeshwar Singh, Charles Ding, Kathy Cao, Jacob J. Plattner, Ligong Ou, Guofeng Jia, Neerja Saraswat, Sreekanth Ramachandran, Ding Zhou
  • Publication number: 20100292504
    Abstract: This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
    Type: Application
    Filed: July 30, 2010
    Publication date: November 18, 2010
    Applicant: Anacor Pharmaceuticals, Inc.
    Inventors: Stephen J. Baker, Vincent S. Hernandez, Rashmi Sharma, James A. Nieman, Tsutomu Akama, Yong-Kang Zhang, Jacob J. Plattner, Michael Richard Kevin Alley, Rajeshwar Singh, Fernando Rock